"indian-pharmaceutical-market-ipm"

The growth was attributed to acute therapy products primarily in anti-infective, gastro and vitamin segments.

Accordingly, the report cited a YoY volume growth of 0.3 per cent, price growth of 5 per cent and products launches at 3.1 per cent during December 2020.